Cart
sales@molnova.com
Kanosamine
CAS No. 576-44-3
Kanosamine( 3-Amino-3-deoxyglucose )
Catalog No. M27774 CAS No. 576-44-3
Kanosamine is an antifungal agent produced by a Streptomyces sp.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 256 | In Stock |
|
| 5MG | 320 | In Stock |
|
| 10MG | 458 | In Stock |
|
| 25MG | 750 | In Stock |
|
| 50MG | 1004 | In Stock |
|
| 100MG | 1376 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2762 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameKanosamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionKanosamine is an antifungal agent produced by a Streptomyces sp.
-
DescriptionKanosamine is an antifungal agent produced by a Streptomyces sp.
-
In Vitro——
-
In Vivo——
-
Synonyms3-Amino-3-deoxyglucose
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorIDH1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number576-44-3
-
Formula Weight179.172
-
Molecular FormulaC6H13NO5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN[C@H]([C@@H](O)C=O)[C@H](O)[C@H](O)CO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang H, Fang X, Meng Q, Mao Y, Xu Y, Fan T, An J, Huang Z. Design, synthesis and characterization of potent microtubule inhibitors with dual anti-proliferative and anti-angiogenic activities. Eur J Med Chem. 2018 Sep 5;157:380-396.
molnova catalog
related products
-
1835F03
1835F03 is a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus.
-
Ceftolozane sulfate
Ceftolozane sulfate (FR-264205) is a cephalosporin antibiotic with broad-spectrum antimicrobial activity, inhibits P. aeruginosa PAO1, inhibits Pseudomonas aeruginosa, and is used in the study of pneumonia.
-
PAβN dihydrochloride
PAβN dihydrochloride is an inhibitor of efflux pump. PAβN reduces the MICs in nine ciprofloxacin-resistant isolates, and in four of these, PAβN increases the susceptibility by twofold.?
